Treatment with ORP100S upregulated KLF4 expression in EML cells but had no effect on KLF4 in EG7 cancer cells whereas rhTRX increased KLF4 several fold versus control in EG7 and to a lesser extent in EML (Figure 8I–K). This evidence concerns the gene KLF4 and cancer.